Initiator Pharma A/S (STO:INIT)
Sweden · Delayed Price · Currency is SEK 1.810
-0.135 (-6.94%)
Nov 2, 2026, 5:29 PM CET
Initiator Pharma Market Cap
Initiator Pharma has a market cap or net worth of 123.9 million as of November 2, 2026. It is the 39,592nd most valuable company in the world and the 561st biggest in Sweden. Its market cap has decreased by 38.01% in one year.
Market Cap
123.90M
Enterprise Value
112.94M
Revenue
n/a
Global Rank
Country Rank
#561 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since March 16, 2017, Initiator Pharma's market cap has increased from 50.37M to 123.90M, an increase of 145.99%. That is a compound annual growth rate of 9.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 123.90M | -38.85% |
| Dec 30, 2025 | 202.62M | -47.31% |
| Dec 30, 2024 | 384.53M | -20.69% |
| Dec 29, 2023 | 484.84M | 52.80% |
| Dec 30, 2022 | 317.31M | -10.94% |
| Dec 30, 2021 | 356.31M | 167.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Elicera Therapeutics AB | 178.19M |
| Diamyd Medical AB | 154.52M |
| Simris Group AB (PUBL) | 152.53M |
| Abera Bioscience AB | 140.62M |
| Xintela AB | 134.36M |
| Active Biotech AB | 107.55M |
| Biovica International AB | 107.42M |
| Alzinova AB | 104.77M |